1. Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis

    http://dx.doi.org/10.1177/1352458518813110
  2. Not all side effects are unwelcome …

    http://dx.doi.org/10.1177/1352458519861278
  3. Infusion-related events during natalizumab: No need for post-infusion monitoring

    http://dx.doi.org/10.1177/1352458519860415
  4. Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review

    http://dx.doi.org/10.1177/1352458519879094
  5. MOG antibody–associated encephalomyelitis/encephalitis

    http://dx.doi.org/10.1177/1352458519837705
  6. MOG-related disorders: A new cause of imaging-negative myelitis?

    http://dx.doi.org/10.1177/1352458519840746
  7. Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort

    http://dx.doi.org/10.1177/1352458519863781
  8. Expanding the spectrum of MOG antibody disease

    http://dx.doi.org/10.1177/1352458519841824
  9. Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis

    http://dx.doi.org/10.1177/1352458519865989
  10. Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

    http://dx.doi.org/10.1177/1352458519863983
Copyright © 2015 1352-4585的搜索结果由GYCC学术搜索提供 - 意见反馈 >>小额捐赠|打赏